Agreement between WHO-UMC causality scale and the Naranjo algorithm for causality assessment of adverse drug reactions AK Shukla, R Jhaj, S Misra, SN Ahmed, M Nanda, D Chaudhary Journal of family medicine and primary care 10 (9), 3303-3308, 2021 | 61 | 2021 |
Cost analysis of antiepileptic drugs available in India AK Shukla, R Mehani Int J Basic Clin Pharmacol 5 (4), 1636-40, 2016 | 20 | 2016 |
An observational multi-centric COVID-19 sequelae study among health care workers AK Shukla, S Atal, A Banerjee, R Jhaj, S Balakrishnan, PK Chugh, ... The Lancet Regional Health-Southeast Asia 10, 2023 | 19 | 2023 |
Hydroxychloroquine for SARS CoV2 Prophylaxis in Healthcare Workers-A Multicentric Cohort Study Assessing Effectiveness and Safety. B Dinesh, J CS, CP Kaur, F Atiya, G Yk, H Avijit, K Sandhya, K Vp, ... The Journal of the Association of Physicians of India 69 (6), 11-12, 2021 | 12 | 2021 |
Comparative study of tramadol and diclofenac as analgesic for postoperative pain AK Shukla, AK Srivastav Int J Med Res Rev 3 (11), 1311-1316, 2015 | 12 | 2015 |
Cost variation analysis of antidyslipidemic drugs PS AK Shukla Int J Basic Clin Pharmacol 5 (5), 1850-5, 2016 | 9 | 2016 |
Antibody-dependent enhancement of virus infection and disease: implications in COVID-19 AK Shukla, S Misra Journal of Basic and Clinical Physiology and Pharmacology 33 (1), 13-16, 2022 | 8 | 2022 |
Antimicrobials in COVID-19: strategies for treating a COVID-19 pandemic AK Shukla, S Misra Journal of Basic and Clinical Physiology and Pharmacology 34 (4), 429-444, 2023 | 7 | 2023 |
An overview of post COVID sequelae AK Shukla, S Misra Journal of basic and clinical physiology and pharmacology 33 (6), 715-726, 2022 | 7 | 2022 |
Cost variation study of antidepressant drugs AK Shukla, P Sharma International Journal of Basic & Clinical Pharmacology 5 (5), 1816-1822, 2016 | 7 | 2016 |
Stimulated reporting of adverse events following immunization with COVID-19 vaccines R Jhaj, D Chaudhary, AK Shukla, J Yadav Vaccines 10 (12), 2133, 2022 | 6 | 2022 |
Brexanolone: Panacea for postpartum depression? Reply to:‘Intravenous brexanolone for postpartum depression: What it is, how well does it work, and will it be used?’ AK Shukla, R Jhaj, B Sadasivam Therapeutic Advances in Psychopharmacology 11, 2045125321997293, 2021 | 6 | 2021 |
Cost analysis of antipsychotic drugs available in India AK Shukla, A Agnihotri Int J Basic Clin Pharmacol 6 (3), 669-74, 2017 | 6 | 2017 |
Teplizumab: type 1 diabetes mellitus preventable? S Misra, AK Shukla European Journal of Clinical Pharmacology 79 (5), 609-616, 2023 | 5 | 2023 |
Clinical implications of anti-idiotype antibodies in COVID-19 AK Shukla, S Misra Journal of Basic and Clinical Physiology and Pharmacology 33 (6), 727-733, 2022 | 5 | 2022 |
Comparative study of tramadol and piroxicam as analgesic for postoperative pain in patients operated for inguinal hernia and hydrocele AK Shukla, M Raja, AK Srivastav Int J Basic Clin Pharmacol 5, 312-16, 2016 | 5 | 2016 |
Assessment of prescribing pattern of drugs and completeness of prescriptions as per the World Health Organization prescribing indicators in various Indian tertiary care centers … R Joshi, B Medhi, A Prakash, S Chandy, J Ranjalkar, HR Bright, J Basker, ... Indian Journal of Pharmacology 54 (5), 321-328, 2022 | 4 | 2022 |
Comparative study of telmisartan and ramipril as an antihypertensive in mild to moderate hypertension M Raja, AK Shukla, R Mehani, A Agnihotri National Journal of Physiology, Pharmacy and Pharmacology 6 (5), 388-388, 1970 | 4 | 1970 |
Evidences and therapeutic advantages of donanemab in the treatment of early Alzheimer’s disease AK Shukla, S Misra Journal of Basic and Clinical Physiology and Pharmacology 35 (1-2), 25-29, 2024 | 3 | 2024 |
Health care associated infections, antimicrobial resistance and outcomes in patients admitted to intensive care unit, India: A Five-Year retrospective cohort study S Chenchula, B Sadasivam, A Shukla, S Pathan, Saurabh saigal Journal of Infection Prevention 24 (4), 159-165, 2023 | 3 | 2023 |